Prime Tech Global Ups Stake in ChromaDex

Ticker: NAGE · Form: SC 13D/A · Filed: Aug 21, 2024 · CIK: 1386570

Chromadex Corp. SC 13D/A Filing Summary
FieldDetail
CompanyChromadex Corp. (NAGE)
Form TypeSC 13D/A
Filed DateAug 21, 2024
Risk Levelmedium
Pages16
Reading Time19 min
Key Dollar Amounts$0,001, $32,058,489.15, $1, $13,048,504.47, $1,672,688.07
Sentimentneutral

Sentiment: neutral

Topics: ownership-change, sec-filing, amendment

Related Tickers: CDXC

TL;DR

Prime Tech Global just filed an amendment for ChromaDex, looks like they're increasing their stake.

AI Summary

Prime Tech Global Ltd. has amended its Schedule 13D filing for ChromaDex Corp. on August 21, 2024. The filing indicates a change in beneficial ownership, with Prime Tech Global Ltd. now holding a significant stake in ChromaDex Corp., a company in the medicinal chemicals and botanical products sector.

Why It Matters

This filing signals a potential shift in control or influence over ChromaDex Corp. by Prime Tech Global Ltd., which could impact the company's strategic direction and shareholder value.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership filings can indicate activist investor activity or potential takeovers, introducing uncertainty.

Key Numbers

  • 20240821 — Filing Date (Date of the Schedule 13D/A amendment)

Key Players & Entities

  • Prime Tech Global Ltd (company) — Filing entity
  • ChromaDex Corp. (company) — Subject company
  • ALPHA MOUNT INTERNATIONAL LTD (company) — Group member
  • APEX DYNASTY LTD (company) — Group member
  • LI KA SHING (person) — Group member
  • MAYSPIN MANAGEMENT LTD (company) — Group member

FAQ

What is the specific percentage of ChromaDex Corp. shares beneficially owned by Prime Tech Global Ltd. after this amendment?

The provided text does not specify the exact percentage of shares beneficially owned by Prime Tech Global Ltd. after this amendment.

What was the previous filing date for this Schedule 13D/A for ChromaDex Corp.?

The provided text does not specify the previous filing date, only the current amendment date of 20240821.

Who are the other entities listed as group members in this filing?

The other entities listed as group members are ALPHA MOUNT INTERNATIONAL LTD, APEX DYNASTY LTD, LI KA SHING, and MAYSPIN MANAGEMENT LTD.

What is the primary business of ChromaDex Corp. according to the filing?

ChromaDex Corp. is in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector.

What is the CUSIP number for ChromaDex Corp. common stock mentioned in the filing?

The CUSIP number for ChromaDex Corp. common stock mentioned is 171077407.

Filing Stats: 4,762 words · 19 min read · ~16 pages · Grade level 10.8 · Accepted 2024-08-21 06:05:57

Key Financial Figures

  • $0,001 — TION (Name of Issuer) COMMON STOCK, $0,001 PAR VALUE PER SHARE (Title of Class o
  • $32,058,489.15 — asty, for an aggregate consideration of $32,058,489.15 (the August 2024 Transaction ). At time
  • $1 — espectively. Alpha acquired Winsave for $1 and the assumption of a loan in the pri
  • $13,048,504.47 — on of a loan in the principal amount of $13,048,504.47 from LKSGF in favor of Winsave. Alpha a
  • $1,672,688.07 — on of a loan in the principal amount of $1,672,688.07 from LKSGF in favor of Radiant. Septe
  • $3.1 million — urchasers an aggregate of approximately $3.1 million of Common Stock (2,480,000 Shares) at a
  • $1.25 — ,480,000 Shares) at a purchase price of $1.25 per share (the September 2022 Transacti
  • $1.8 m — d Taikuk have each agreed to contribute $1.8 million, $1.2 million and $1.0 million, r
  • $1.2 million — each agreed to contribute $1.8 million, $1.2 million and $1.0 million, respectively into the
  • $1.0 m — ntribute $1.8 million, $1.2 million and $1.0 million, respectively into the JV. Follow
  • $23 million — urchasers an aggregate of approximately $23 million of Common Stock (5,609,755 Shares) at a
  • $4.10 — ,609,755 Shares) at a purchase price of $4.10 per share (the November 2017 Transactio
  • $25 million — l 2017 Purchasers an aggregate of up to $25 million of its Common Stock at a purchase price
  • $2.60 — its Common Stock at a purchase price of $2.60 per share in three tranches of approxim
  • $3.5 m — hare in three tranches of approximately $3.5 million, $16.4 million and $5.1 million,

Filing Documents

From the Filing

SC 13D/A 1 d875211dsc13da.htm SC 13D/A SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A (Rule 13d-101) INFORMATION INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-l(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 9)* CHROMADEX CORPORATION (Name of Issuer) COMMON STOCK, $0,001 PAR VALUE PER SHARE (Title of Class of Securities) 171077407 (CUSIP Number) Li Ka Shing Attention: Pau Yee Wan Ezra c/o 7/F, Cheung Kong Center 2 Queens Road Central Hong Kong (852)2128-8888 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 20, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d 1(e), 240.13d 1(f) or 240.13d 1(g), check the following box. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7 for other parties to whom copies are to be sent * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) PRIME TECH GLOBAL LIMITED 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)(b) 3. SEC Use Only 4. Source of Funds (See Instructions) AF 5. Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) 6. Citizenship or Place of Organization British Virgin Islands Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 0 8. Shared Voting Power 0 9. Sole Dispositive Power 0 10. Shared Dispositive Power 0 11. Aggregate Amount Beneficially Owned by Each Reporting Person 0 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) 13. Percent of Class Represented by Amount in Row (11) 0% 14. Type of Reporting Person (See Instructions) CO 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) APEX DYNASTY LIMITED 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)(b) 3. SEC Use Only 4. Source of Funds (See Instructions) AF 5. Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) 6. Citizenship or Place of Organization British Virgin Islands Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 0 8. Shared Voting Power 0 9. Sole Dispositive Power 0 10. Shared Dispositive Power 0 11. Aggregate Amount Beneficially Owned by Each Reporting Person 0 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) 13. Percent of Class Represented by Amount in Row (11) 0% 14. Type of Reporting Person (See Instructions) CO 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) ALPHA MOUNT INTERNATIONAL LIMITED 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)(b) 3. SEC Use Only 4. Source of Funds (See Instructions) AF 5. Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) 6. Citizenship or Place of Organization British Virgin Islands Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 0 8. Shared Voting Power 0 9. Sole Dispositive Power 0 10. Shared Dispositive Power 0 11. Aggregate Amount Beneficially Owned by Each Reporting Person 0 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) 13. Percent of Class Represented by Amount in Row (11) 0% 14. Type of Reporting Person (See Instructions) CO 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) MAYSPIN MANAGEMENT LIMITED 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)(b) 3. SEC Use Only 4. Source of Funds (See Instructions) AF 5. Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) 6. Citizenship or Place of Organization British Virgin Islands Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Pow

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.